Brief: Keros Therapeutics Announces Review Of Strategic Alternatives
10/04/2025 11:01
April 10 (Reuters) - Keros Therapeutics Inc KROS.O: KEROS THERAPEUTICS ANNOUNCES REVIEW OF STRATEGIC ALTERNATIVES KEROS THERAPEUTICS INC - AUTHORIZED FORMATION OF COMMITTEE, CONSISTING OF INDEPENDENT AND DISINTERESTED DIRECTORS, TO OVERSEE PROCESS KEROS THERAPEUTICS- INTENDS TO CONSIDER RANGE OF STRATEGIC ALTERNATIVES, INCLUDING BUT NOT LIMITED TO SALE KEROS THERAPEUTICS INC - ADOPTED LIMITED-DURATION STOCKHOLDER RIGHTS PLAN Source text: ID:nGNXbCJbLd Further company coverage: KROS.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops